Science Explorer Back to mapMap
Discussion
Researcher · Welsh Government · United Kingdom

S G Woolfrey

S G Woolfrey publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, on topics such as Cancer Treatment and Pharmacology, Antibiotic Use and Resistance and Lanthanide and Transition Metal Complexes.

OpenAlex
World rank
#2,691,780
of 7,710,434 ranked researchers
Rank in United Kingdom
#187,582
of 367,258
Works
18
Citations
587
Citations per work
32.6
h-index
11
i10-index 12Top 54% in Oncology
S G Woolfrey

What does S G Woolfrey research?

S G Woolfrey's work is mostly in Medicine (35%), Biochemistry, Genetics and Molecular Biology (6%), Materials Science (6%).

Everything else: 10 works · 53.8% of their workHealth Sciences: 6 works · 34.6% of their workMedicine: 6 works · 34.6% of their workOncology: 2 works · 11.5% of their workPulmonary and Respiratory Medicine: 2 works · 9.6% of their workCardiology and Cardiovascular Medicine: 1 works · 7.7% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 5.8% of their workLife Sciences: 1 works · 5.8% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 5.8% of their workMolecular Biology: 1 works · 5.8% of their workPhysical Sciences: 1 works · 5.8% of their workMaterials Science: 1 works · 5.8% of their workMaterials Chemistry: 1 works · 5.8% of their workTHEIR WORKS G Woolfrey18works
Life Sciences6%Physical Sciences6%Health Sciences35%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1053.8%
    1. Medicine634.6%
    1. Biochemistry, Genetics and Molecular Biology15.8%
    1. Materials Science15.8%
  1. 1Oncology12% of their works
  2. 2Pulmonary and Respiratory Medicine10% of their works
  3. 3Cardiology and Cardiovascular Medicine8% of their works
  4. 4Materials Chemistry6% of their works
  5. 5Radiology, Nuclear Medicine and Imaging6% of their works
  6. 6Molecular Biology6% of their works

Research topics

Which keywords describe S G Woolfrey's research?

The keywords of their largest research topics: Drug Development, Epidemiology, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Antibiotic Resistance, Antimicrobial Stewardship, Cisplatin Resistance and Guidelines.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Drug Development42 topics
  2. Epidemiology42 topics
  3. Chemotherapy-Induced Peripheral Neuropathy31 topic
  4. Taxanes31 topic
  5. Antibiotic Resistance21 topic
  6. Antimicrobial Stewardship21 topic
  7. Cisplatin Resistance21 topic
  8. Guidelines21 topic
  9. Heart Failure21 topic
  10. Lanthanide Luminescence21 topic
  11. MRI Contrast Agents21 topic
  12. Off-Label Drug Use21 topic
  13. PET Imaging21 topic
  14. Pediatric Pharmacokinetics21 topic
  15. Platinum-Based Drugs21 topic
  16. Pulmonary Alveolar Microlithiasis21 topic
  17. Pulmonary Sclerosing Hemangioma21 topic
  18. Radiopharmaceuticals21 topic

Where does S G Woolfrey work?

S G Woolfrey's main affiliation in the publication record is Welsh Government, United Kingdom.

How many publications and citations does S G Woolfrey have?

OpenAlex counts 18 works and 587 citations for S G Woolfrey, an h-index of 11, ranking #2,691,780 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about S G Woolfrey. Posts are plain text and can be reported.